BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34303004)

  • 1. Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.
    Stempak-Droissart T; Rousset-Jablonski C; Spritzer PM; Lalhou N; Larger E; Pichard C; Plessier A; Gompel A
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101756. PubMed ID: 34303004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatic vascular diseases.
    Plessier A; Rautou PE; Valla DC
    J Hepatol; 2012; 56 Suppl 1():S25-38. PubMed ID: 22300463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
    Moran LJ; Teede HJ; Noakes M; Clifton PM; Norman RJ; Wittert GA
    J Endocrinol Invest; 2013 Dec; 36(11):1004-10. PubMed ID: 23812344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
    Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L
    Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual Pattern, Reproductive Hormones, and Transabdominal 3D Ultrasound in 317 Adolescent Girls.
    Assens M; Dyre L; Henriksen LS; Brocks V; Sundberg K; Jensen LN; Pedersen AT; Main KM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32506132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between blood cadmium and endocrine features related to PCOS-phenotypes in healthy women of reproductive age: a prospective cohort study.
    Kim K; Pollack AZ; Nobles CJ; Sjaarda LA; Zolton JR; Radoc JG; Schisterman EF; Mumford SL
    Environ Health; 2021 May; 20(1):64. PubMed ID: 34022900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.
    Giuli L; Pallozzi M; Venturini G; Gasbarrini A; Ponziani FR; Santopaolo F
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
    Morin-Papunen LC; Koivunen RM; Ruokonen A; Martikainen HK
    Fertil Steril; 1998 Apr; 69(4):691-6. PubMed ID: 9548159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.
    Simons PIHG; Valkenburg O; Bons JAP; Stehouwer CDA; Brouwers MCGJ
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00267. PubMed ID: 34277990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.